Lupin gets US FDA nod for generic drug Lenalidomide in multiple potencies

The announcement comes a day after Lupin said the US FDA had inspected its Nagpur injectable facility between September 8 and ...

Lupin gets USFDA nod for generic cancer drug Lenalidomide capsules

Lupin has received USFDA approval to market generic Lenalidomide capsules, a version of Bristol-Myers Squibb's cancer drug Revlimid, which posted $7.5 bn US sales in July 2025 ...
Devdiscourse

Lupin Gains USFDA Approval for Cancer Drug Lenalidomide

Lupin has been granted approval by the USFDA to market Lenalidomide Capsules, a cancer treatment drug, in the US. The drug, a bioequivalent to Revlimid by Bristol-Myers Squibb, will be produced at ...
NDTV Profit on MSN

Lupin Gets US FDA Approval For Generic Lenalidomide Capsules

Lenalidomide Capsules are indicated for the treatment of adult patients with Multiple myeloma, in combination with ...
TipRanks on MSN

Lupin Limited Gains U.S. FDA Approval for Lenalidomide Capsules

Lupin Limited ( ($IN:LUPIN) ) has issued an update. Lupin Limited has announced that it has received approval from the U.S. FDA for its ...

Lupin gets U.S. FDA nod for generic of cancer drug Revlimid capsules

Lupin receives FDA approval for Lenalidomide Capsules, a generic version of Revlimid, for multiple myeloma treatment.
AOL

Does Medicare cover Revlimid?

Revlimid (lenalidomide) is a brand-name drug that doctors may prescribe to treat certain cancers of the blood. If a person has a Medicare Part D prescription drug plan or a Medicare Advantage (Part C) ...